Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

962 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Zodasiran, an RNAi Therapeutic Targeting ANGPTL3, for Mixed Hyperlipidemia.
Rosenson RS, Gaudet D, Hegele RA, Ballantyne CM, Nicholls SJ, Lucas KJ, San Martin J, Zhou R, Muhsin M, Chang T, Hellawell J, Watts GF; ARCHES-2 Trial Team. Rosenson RS, et al. Among authors: hegele ra. N Engl J Med. 2024 Sep 12;391(10):913-925. doi: 10.1056/NEJMoa2404147. Epub 2024 May 29. N Engl J Med. 2024. PMID: 38809174 Clinical Trial.
Plozasiran for Managing Persistent Chylomicronemia and Pancreatitis Risk.
Watts GF, Rosenson RS, Hegele RA, Goldberg IJ, Gallo A, Mertens A, Baass A, Zhou R, Muhsin M, Hellawell J, Leeper NJ, Gaudet D; PALISADE Study Group. Watts GF, et al. Among authors: hegele ra. N Engl J Med. 2024 Sep 2. doi: 10.1056/NEJMoa2409368. Online ahead of print. N Engl J Med. 2024. PMID: 39225259
Sex Differences in Diagnosis, Treatment, and Cardiovascular Outcomes in Homozygous Familial Hypercholesterolemia.
Mulder JWCM, Tromp TR, Al-Khnifsawi M, Blom DJ, Chlebus K, Cuchel M, D'Erasmo L, Gallo A, Hovingh GK, Kim NT, Long J, Raal FJ, Schonck WAM, Soran H, Truong TH, Boersma E, Roeters van Lennep JE; Homozygous Familial Hypercholesterolemia International Clinical Collaborators. Mulder JWCM, et al. JAMA Cardiol. 2024 Apr 1;9(4):313-322. doi: 10.1001/jamacardio.2023.5597. JAMA Cardiol. 2024. PMID: 38353972
Homocysteine, neurodegenerative biomarkers, and APOE ε4 in neurodegenerative diseases.
Lin WZ, Yu D, Xiong LY, Zebarth J, Wang R, Fischer CE, Rajji TK, Tang-Wai DF, Tartaglia C, Saposnik G, Swartz RH, Grimes DA, Lang AE, Hegele RA, Farhan S, Ramirez J, Symons S, Goubran M, Binns MA, Lou W, Dixon RA, Orange JB, Roberts AC, Troyer AK, Zetterberg H, Herrmann N, Rabin JS, MacIntosh BJ, Masellis M, Lanctôt KL, Black SE, Swardfager W; ONDRI Investigators. Lin WZ, et al. Among authors: hegele ra. Alzheimers Dement. 2024 Nov 19. doi: 10.1002/alz.14376. Online ahead of print. Alzheimers Dement. 2024. PMID: 39559926
Temporal Effects of Plozasiran on Lipids and Lipoproteins in Persistent Chylomicronemia.
Watts GF, Hegele RA, Rosenson RS, Goldberg IJ, Gallo A, Mertens A, Baass A, Zhou R, Muhsin M, Hellawell J, Gaudet D, Leeper NJ; PALISADE Study Group. Watts GF, et al. Among authors: hegele ra. Circulation. 2024 Nov 16. doi: 10.1161/CIRCULATIONAHA.124.072860. Online ahead of print. Circulation. 2024. PMID: 39549263 Free article. No abstract available.
Dysbetalipoproteinemia: focus on a neglected lipid disorder.
Berberich AJ, Hegele RA. Berberich AJ, et al. Among authors: hegele ra. J Clin Endocrinol Metab. 2024 Nov 14:dgae804. doi: 10.1210/clinem/dgae804. Online ahead of print. J Clin Endocrinol Metab. 2024. PMID: 39541420 No abstract available.
Development and validation of clinical criteria to identify familial chylomicronemia syndrome (FCS) in North America.
Hegele RA, Ahmad Z, Ashraf A, Baldassarra A, Brown AS, Chait A, Freedman SD, Kohn B, Miller M, Patni N, Soffer DE, Wang J, Broder MS, Chang E, Yermilov I, Campos C, Gibbs SN. Hegele RA, et al. J Clin Lipidol. 2024 Nov 12:S1933-2874(24)00251-4. doi: 10.1016/j.jacl.2024.09.008. Online ahead of print. J Clin Lipidol. 2024. PMID: 39537503 Free article.
962 results